HIST1H2BB and MAGI2 methylation and somatic mutations in different samples are promising biomarkers for diagnosis and prognosis of high-grade serous ovarian cancer
Más información
Título de la Revista: | CANCER PREVENTION RESEARCH |
Editorial: | AMER ASSOC CANCER RESEARCH |
Fecha de publicación: | 2020 |